Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
Department of Surgery, Boston University School of Medicine, Boston, Mass.
J Thorac Cardiovasc Surg. 2023 Oct;166(4):1087-1096.e5. doi: 10.1016/j.jtcvs.2022.01.034. Epub 2022 Feb 3.
Studies have noted racial/ethnic disparities in coronary artery disease intervention strategies. We investigated trends and outcomes of coronary artery disease treatment choice (coronary artery bypass grafting or percutaneous coronary intervention) stratified by race/ethnicity.
We queried the National Inpatient Sample for patients who underwent isolated coronary artery bypass grafting or percutaneous coronary intervention (2002-2017). Outcomes were stratified by race/ethnicity (White, African American, Hispanic, Asian). Multivariable logistic regression evaluated associations between race/ethnicity and receiving coronary artery bypass grafting versus percutaneous coronary intervention, in-hospital mortality, and costs.
Over the 15-year period, 2,426,917 isolated coronary artery bypass grafting surgeries and 7,184,515 percutaneous coronary interventions were performed. Compared with White patients, African American patients were younger (62 [interquartile range, 53-70] vs 66 [interquartile range, 57-75] years), were more likely to have Medicaid insurance (12.2% vs 4.4%), and had more comorbidities (Charlson-Deyo index, 1.9 ± 1.6 vs 1.7 ± 1.6) (all P < .01). After adjustment for patient comorbidities, presence of acute myocardial infarction, insurance status, and geography, African Americans were the least likely of all racial/ethnic groups to undergo coronary artery bypass grafting (odds ratio, 0.76; P < .01), a consistent trend throughout the study. African American patients had higher risk-adjusted mortality after coronary artery bypass grafting (odds ratio, 1.09; P < .01). Race/ethnicity was not associated with increased mortality after percutaneous coronary intervention. African American patients had higher hospitalization costs for coronary artery bypass grafting (+$5816; P < .01) and percutaneous coronary intervention (+$856; P < .01) after controlling for confounders.
In this contemporary national analysis, risk-adjusted frequency of coronary artery bypass grafting versus percutaneous coronary intervention for coronary artery disease differed by race/ethnicity. African American patients had lower odds of undergoing coronary artery bypass grafting and worse outcomes. Reasons for these differences merit further investigation to identify opportunities to reduce potential disparities.
研究表明,在冠状动脉疾病干预策略方面存在种族/民族差异。我们调查了按种族/民族分层的冠状动脉疾病治疗选择(冠状动脉旁路移植术或经皮冠状动脉介入治疗)的趋势和结果。
我们在全国住院患者样本中查询了 2002 年至 2017 年间接受单纯冠状动脉旁路移植术或经皮冠状动脉介入治疗的患者。结果按种族/民族(白人、非裔美国人、西班牙裔、亚裔)分层。多变量逻辑回归评估了种族/民族与接受冠状动脉旁路移植术与经皮冠状动脉介入治疗、住院死亡率和成本之间的关联。
在 15 年期间,共进行了 2426917 例单纯冠状动脉旁路移植术和 7184515 例经皮冠状动脉介入治疗。与白人患者相比,非裔美国人患者年龄较小(62 [四分位间距,53-70] vs 66 [四分位间距,57-75]岁),更有可能拥有医疗补助保险(12.2% vs 4.4%),且合并症更多(Charlson-Deyo 指数,1.9±1.6 vs 1.7±1.6)(均 P<0.01)。在调整了患者合并症、急性心肌梗死的存在、保险状况和地理位置后,非裔美国人是所有种族/民族中最不可能接受冠状动脉旁路移植术的人群(比值比,0.76;P<0.01),这是整个研究中的一致趋势。非裔美国人患者在接受冠状动脉旁路移植术后的风险调整死亡率更高(比值比,1.09;P<0.01)。种族/民族与经皮冠状动脉介入治疗后的死亡率增加无关。非裔美国人患者在接受冠状动脉旁路移植术和经皮冠状动脉介入治疗后的住院费用更高(冠状动脉旁路移植术增加$5816;P<0.01)和经皮冠状动脉介入治疗增加$856;P<0.01),在控制混杂因素后。
在这项当代全国性分析中,按种族/民族分层的冠状动脉疾病冠状动脉旁路移植术与经皮冠状动脉介入治疗的风险调整频率不同。非裔美国人患者接受冠状动脉旁路移植术的几率较低,结局较差。这些差异的原因值得进一步研究,以确定减少潜在差异的机会。